United States · FDA National Drug Code directory
Pyrazinamide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70954-484_e043f21d-4a30-4d23-bc03-12207af7d6d7
- Product NDC
- 70954-484
- Form
- TABLET
- Composition / generic term
- Pyrazinamide
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210511
- Source listing expiry
- 20271231
Source-listed ingredients
- PYRAZINAMIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (70954-484-10) · 70954-484-10
- 90 TABLET in 1 BOTTLE (70954-484-20) · 70954-484-20
- 100 TABLET in 1 BOTTLE (70954-484-30) · 70954-484-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →